Drug profile · INN
nivolumab + relatlimab
OPDUALAG
- Patents linked
- 0
- News articles
- 0
Quick answer
nivolumab + relatlimab (OPDUALAG) is an FDA-listed pharmaceutical active ingredient. Associated with Bristol-Myers Squibb Australia Pty Ltd.
Key facts
Frequently asked questions
What is nivolumab + relatlimab?
nivolumab + relatlimab (OPDUALAG) is an FDA-listed pharmaceutical active ingredient. Associated with Bristol-Myers Squibb Australia Pty Ltd.
What is the brand name for nivolumab + relatlimab?
OPDUALAG is a marketed brand name for nivolumab + relatlimab. Check FDA Drugs@FDA for the current US label holder and prescribing information.